Korea drug regulator issues patient guide for narcotic painkillers
The food and drug safety ministry and the Korean Pain Society jointly produced a leaflet explaining when prescription opioid analgesics should be used and the risks of misuse.

South Korea's food and drug safety ministry said it has jointly produced a patient information leaflet on the safe use of medical narcotic painkillers with the Korean Pain Society, as part of efforts to curb misuse of the prescription drugs.
The leaflet, titled "Guidance for Patients on the Safe Use of Medical Narcotic Analgesics," sets out when the drugs should be used and what patients need to know before taking them. It is being distributed to patients and medical staff as training material and will also be handed out at the pain society's annual academic conference, which runs from Nov. 20 to 22.
The guidance states that narcotic analgesics — including morphine, oxycodone, pethidine and fentanyl — should not be used as a first-line treatment. They are intended for severe pain that cannot be controlled with non-drug treatments such as cognitive behavioral therapy and physical therapy, or with non-narcotic pain relievers such as acetaminophen.
The drugs deliver strong pain relief but carry a substantial risk of dependence and addiction when misused, and can cause fatal adverse reactions such as coma and respiratory depression. The leaflet also warns that taking them with alcohol or with other medical narcotics raises the risk of excessive drowsiness, dizziness and slowed breathing. Patients are advised never to share prescribed narcotic painkillers with anyone else, including family members.
The pain society said narcotic analgesics must be used only under the professional judgment of medical staff, and expressed hope that the leaflet will give patients accurate information about the drugs and encourage both patients and doctors to take part in efforts to use them safely.
A patient group representing people with complex regional pain syndrome said the drugs are essential for patients whose daily lives are restricted by severe, persistent pain, and called the cooperation between the ministry and the pain society highly meaningful. The ministry said it will continue to provide information and education to patients and medical staff to prevent misuse and support appropriate use by patients in treatment.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Government식품의약품안전처 정부 보도자료· Ministry of Food and Drug Safety· accessed Nov. 20, 2026
- Government발표 주체·성격· mfds.go.kr· accessed Nov. 20, 2026
© New Era Korea Daily. All rights reserved.